$1.20
0[0.00%]
At close: Apr 18
Lineage Cell Therapeutics
(AMEX:LCTX)Lineage Cell Therapeutics Stock (AMEX:LCTX), Earnings Estimates, EPS, and Revenue
Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$1.4M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$8.9M
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | LCTX | Q1 | -$0.03 | -$0.04 | — | — | $2.39M | $1.36M | — | — | Get Alert |
| 03/07/2024 | PM | LCTX | Q4 | -$0.03 | -$0.04 | -$0.03 | 25.00% | $1.90M | $1.31M | $2.10M | 60.31% | Get Alert |
| 11/09/2023 | PM | LCTX | Q3 | -$0.04 | -$0.04 | -$0.04 | 0.00% | $3.00M | $2.59M | $1.25M | -51.89% | Get Alert |
| 08/10/2023 | PM | LCTX | Q2 | -$0.04 | -$0.04 | -$0.03 | 25.00% | $4.55M | $2.20M | $3.23M | 46.59% | Get Alert |
| 05/11/2023 | PM | LCTX | Q1 | -$0.04 | -$0.04 | -$0.03 | 25.00% | $5.24M | $2.01M | $2.39M | 18.71% | Get Alert |
| 03/09/2023 | PM | LCTX | Q4 | -$0.17 | -$0.04 | -$0.03 | 25.00% | $1.20M | $2.57M | $1.90M | -26.07% | Get Alert |
| 11/10/2022 | PM | LCTX | Q3 | -$0.05 | -$0.03 | -$0.04 | -33.33% | $2.27M | $3.90M | $3.00M | -23.13% | Get Alert |
| 08/11/2022 | PM | LCTX | Q2 | -$0.03 | -$0.04 | -$0.04 | 0.00% | $512.00K | $3.68M | $4.55M | 23.72% | Get Alert |
| 05/12/2022 | PM | LCTX | Q1 | -$0.01 | -$0.03 | -$0.04 | -33.33% | $391.00K | $7.32M | $5.24M | -28.46% | Get Alert |
| 03/10/2022 | PM | LCTX | Q4 | $0.01 | -$0.05 | -$0.17 | -240.00% | $355.00K | $840.00K | $1.20M | 42.86% | Get Alert |
| 11/10/2021 | PM | LCTX | Q3 | -$0.05 | -$0.05 | -$0.05 | 0.00% | $571.00K | — | $2.27M | — | Get Alert |
| 08/12/2021 | PM | LCTX | Q2 | -$0.04 | -$0.04 | -$0.03 | 25.00% | $386.00K | $480.00K | $512.00K | 6.67% | Get Alert |
| 05/13/2021 | PM | LCTX | Q1 | -$0.06 | -$0.04 | -$0.01 | 75.00% | $514.00K | $790.00K | $391.00K | -50.51% | Get Alert |
| 03/11/2021 | PM | LCTX | Q4 | -$0.03 | -$0.05 | $0.01 | 120.00% | $1.24M | $920.00K | $355.00K | -61.41% | Get Alert |
| 11/04/2020 | PM | LCTX | Q3 | -$0.11 | -$0.04 | -$0.05 | -25.00% | $567.00K | $430.00K | $571.00K | 32.79% | Get Alert |
| 08/06/2020 | PM | LCTX | Q2 | -$0.20 | -$0.04 | -$0.04 | 0.00% | $779.00K | $560.00K | $386.00K | -31.07% | Get Alert |
| 05/07/2020 | PM | LCTX | Q1 | $0.30 | -$0.05 | -$0.06 | -20.00% | $928.00K | $710.00K | $514.00K | -27.61% | Get Alert |
| 03/12/2020 | PM | LCTX | Q4 | -$0.36 | -$0.05 | -$0.03 | 40.00% | $758.00K | $1.03M | $1.24M | 20.49% | Get Alert |
| 11/12/2019 | PM | LCTX | Q3 | $0.53 | -$0.05 | -$0.11 | -120.00% | $982.00K | $810.00K | $567.00K | -30.00% | Get Alert |
FAQ
When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?
Lineage Cell Therapeutics (LCTX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
What were the latest earnings per share (EPS) for Lineage Cell Therapeutics (AMEX:LCTX)?
The Actual EPS was $-0.03, which beat the estimate of $-0.04.
What were Lineage Cell Therapeutics’s (AMEX:LCTX) revenues?
The Actual Revenue was $2.1M, which beat the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.